Central nervous system primitive neuroectodermal tumor: Difference between revisions

Revision as of 10:34, 24 February 2019

Revision as of 23:52, 24 February 2019

Line 30:

There is not a standardized procedure to treat primitive neuroectodermal tumors.<ref name=":1" /> Better outcomes, however, have been seen when patients are treated with risk-adapted radiotherapy combined with chemotherapy and stem cell rescue.<ref name=":0" /> For patients younger than 2-3 years of age, treatment with radiation are not used, once they are in a more vulnerable phase and, thus, more prone to risks in development. <ref name=":0" /> Examinations such as CSF analysis and spinal MRIs are used to investigate the effectiveness of treatment in preventing metastasis.<ref name=":1" />

A method for eliminating tumorous mass is surgery, where the best outcome would be total resection, meaning the complete removal of the tumor.<ref name=":1" /> [The term "total resection' will be defined] Along with the surgery, several measures that contribute to a safe procedure can be taken: urine exams, transfusion, and the constant supervision of arterial pressure.<ref name=":1" /> Possible problems that arise from the surgery include hemorrhage, brain edema, and hemiparesis.<ref name=":1" /> MRIs are typically done after 1 or 2 days of postoperative in order to inspect the amount of tumor remaining.<ref name=":1" />

== Prognosis ==